1. An analysis of the phosphoproteome of immune cell lines exposed to the immunomodulatory mycotoxin deoxynivalenol.
- Author
-
Nogueira da Costa A, Keen JN, Wild CP, and Findlay JB
- Subjects
- B-Lymphocytes drug effects, B-Lymphocytes metabolism, Cell Line, Cell Line, Tumor, Cell Survival drug effects, Dose-Response Relationship, Drug, Electrophoresis, Gel, Two-Dimensional, Flow Cytometry, Humans, Lymphocytes metabolism, Mycotoxins pharmacology, Phosphorylation drug effects, Proteome metabolism, Reproducibility of Results, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, T-Lymphocytes drug effects, T-Lymphocytes metabolism, Time Factors, Lymphocytes drug effects, Phosphoproteins analysis, Proteome analysis, Proteomics methods, Trichothecenes pharmacology
- Abstract
The mycotoxin deoxynivalenol (DON) commonly contaminates cereal grains. It is ubiquitous in the Western European diet, although chronic, low-dose effects in humans are not well described, but immunotoxicity has been reported. In this study, two-dimensional gel electrophoresis was used to identify phosphoproteomic changes in human B (RPMI1788) and T (Jurkat E6.1) lymphocyte cell lines after exposure to modest concentrations of DON (up to 500ng/mL) for 24h. Proteins identified as having altered phosphorylation state post-treatment (C-1-tetrahydrofolate synthase, eukaryotic elongation factor 2, nucleoside diphosphate kinase A, heat shock cognate 71kDa protein, eukaryotic translation initiation factor 3 subunit I and growth factor receptor-bound protein 2) are involved in regulation of metabolic pathways, protein biosynthesis and signaling transduction. All exhibited a greater than 1.4-fold change, reproducible in three separate experiments consisting of 36 gels in total. Flow cytometry validated the observations for eukaryotic elongation factor 2 and growth factor receptor-bound protein 2. These findings provide further insights as to how low dose exposure to DON may affect human immune function and may have potential as mechanism-based phosphoprotein biomarkers for DON exposure., (2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF